Search
Tildacerfont
go.drugbank.com/drugs/DB18545InvestigationalTildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring
Dapiglutide
go.drugbank.com/drugs/DB19182InvestigationalDapiglutide is under investigation in clinical trial NCT05788601 (Dapiglutide for the Treatment of Obesity).
Synonyms: -ASPARTYL-N6-(N-(17-CARBOXY-1-OXOHEPTADECYL)-L-.GAMMA.-GLUTAMYL)-L, -glutamyl)- (a2>aib (2-methylalanine), d3>e, s7>t, d8>s, m10>l, n11>a, n16>k, l17>q, n24>a, t29>h)human glucagonlike peptide 2 (glp-2)Anfibatide
go.drugbank.com/drugs/DB15094InvestigationalAnfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).
Nattokinase
go.drugbank.com/drugs/DB15329InvestigationalNattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).
Vidofludimus
go.drugbank.com/drugs/DB15446InvestigationalVidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing Cholangitis).
Amfenac
go.drugbank.com/drugs/DB15911InvestigationalAmfenac is an arylacetic acid derivative and a non0steroidal anti-inflammatory agent.[A275203, A275208]
AKN-028
go.drugbank.com/drugs/DB12746InvestigationalAKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.
MK-1496
go.drugbank.com/drugs/DB12763InvestigationalMK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
Crotedumab
go.drugbank.com/drugs/DB12815InvestigationalCrotedumab has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Tetrasul
go.drugbank.com/drugs/DB12838InvestigationalTetrasul has been used in trials studying the treatment of Erythematous (Type One) Rosacea.